The endocannabinoid system in brain reward processes
- PMID: 18414385
- PMCID: "V体育ios版" PMC2442437
- DOI: 10.1038/bjp.2008.130
The endocannabinoid system in brain reward processes
Abstract
Food, drugs and brain stimulation can serve as strong rewarding stimuli and are all believed to activate common brain circuits that evolved in mammals to favour fitness and survival. For decades, endogenous dopaminergic and opioid systems have been considered the most important systems in mediating brain reward processes VSports手机版. Recent evidence suggests that the endogenous cannabinoid (endocannabinoid) system also has an important role in signalling of rewarding events. First, CB(1) receptors are found in brain areas involved in reward processes, such as the dopaminergic mesolimbic system. Second, activation of CB(1) receptors by plant-derived, synthetic or endogenous CB(1) receptor agonists stimulates dopaminergic neurotransmission, produces rewarding effects and increases rewarding effects of abused drugs and food. Third, pharmacological or genetic blockade of CB(1) receptors prevents activation of dopaminergic neurotransmission by several addictive drugs and reduces rewarding effects of food and these drugs. Fourth, brain levels of the endocannabinoids anandamide and 2-arachidonoylglycerol are altered by activation of reward processes. However, the intrinsic activity of the endocannabinoid system does not appear to play a facilitatory role in brain stimulation reward and some evidence suggests it may even oppose it. The influence of the endocannabinoid system on brain reward processes may depend on the degree of activation of the different brain areas involved and might represent a mechanism for fine-tuning dopaminergic activity. Although involvement of the various components of the endocannabinoid system may differ depending on the type of rewarding event investigated, this system appears to play a major role in modulating reward processes. .
References
- 
    - Abel EL. Cannabis: effects on hunger and thirst. Behav Biol. 1975;15:255–281. - PubMed
 
- 
    - Antoniou K, Galanopoulos A, Vlachou S, Kourouli T, Nahmias V, Thermos K, et al. Behavioral pharmacological properties of a novel cannabinoid 1′,1′-dithiolane delta8-THC analog, AMG-3. Behav Pharmacol. 2005;16:499–510. - "VSports app下载" PubMed
 
- 
    - Arnold JC, Hunt GE, McGregor IS. Effects of the cannabinoid receptor agonist CP 55,940 and the cannabinoid receptor antagonist SR 141716 on intracranial self-stimulation in Lewis rats. Life Sci. 2001;70:97–108. - PubMed
 
- 
    - Arnold JM, Roberts DC. A critique of fixed and progressive ratio schedules used to examine the neural substrates of drug reinforcement. Pharmacol Biochem Behav. 1997;57:441–447. - PubMed
 
- 
    - Arnone M, Maruani J, Chaperon F, Thiebot MH, Poncelet M, Soubrie P, et al. Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology (Berl) 1997;132:104–106. - PubMed (VSports)
 
V体育官网 - Publication types
- V体育官网入口 - Actions
- V体育官网入口 - Actions
- V体育安卓版 - Actions
MeSH terms
- "VSports在线直播" Actions
- "VSports最新版本" Actions
- VSports注册入口 - Actions
- Actions (V体育官网入口)
- VSports - Actions
- Actions (V体育平台登录)
Substances
- "VSports注册入口" Actions
- VSports - Actions
- "VSports手机版" Actions
- "V体育官网入口" Actions
- Actions (V体育官网)
- "VSports" Actions
Grants and funding
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
 
        